Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

A new study aims to help healthcare providers more effectively implement Apretude, a medication used for HIV prevention.

If an HIV-negative person takes PrEP daily and is exposed to the virus, the medication can prevent the virus from taking hold in their body. This mechanism makes PrEP a powerful tool in the fight ...

"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.

PrEP is an antiretroviral medication proven to reduce HIV infections from sex by as much as 99%. It is sold as a daily pill under brand names Truvada and Descovy, as well as generic versions.

Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...

Truvada, often called PrEP, is a daily oral medication that helps reduce the risk of HIV transmission by 90%. Two gay men who take PrEP talk to us about safe sex, HIV stigma, access, and peace of ...

The Food and Drug Administration approved the use of PrEP, short for pre-exposure prophylaxis, as a strategy to prevent people from contracting HIV in 2012. Some were eager to take advantage of ...

The PrEP gap. About 1.1 million Americans are at high risk for HIV and could benefit from PrEP, according to the CDC. Around half of those are black men and women, who have the highest HIV risk ...

A new paper, which reviewed current research on American adolescents and pre-exposure prophylaxis (PrEP), found that this high-risk demographic needs far more attention than it’s getting.